ADVERTISEMENT

Conference Report

IDWeek 2021 — Antibody cocktail effective at preventing symptomatic COVID-19

Pavankumar Kamat   |   11 October 2021

Takeaway

  • A one-time prophylactic dose of the monoclonal antibody cocktail AZD7442 (tixagevimab and cilgavimab) demonstrated a significant reduction in the risk for symptomatic COVID-19 and was well tolerated.

Why this matters

  • For individuals who carry a risk for COVID-19 despite vaccination or those ineligible for vaccination, monoclonal antibodies may provide...

          

November Challenge

Ends in 11h
left
right

Topic Challenges

left
right